Qube Research & Technologies »

Cytokinetics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $286k 9.7k 29.46
2023-06-30 $3.1M 96k 32.62
2023-03-31 $3.6M 103k 35.19
2021-09-30 $442k 12k 35.72
2020-09-30 $298k 14k 21.68
2020-06-30 $562k 24k 23.57

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics